Mirae Asset Global Investments
DCPH

Mirae Asset Global Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Mirae Asset Global Investments’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,370
Closed -$492K – 2667
2024
Q1 		$492K Sell
32,370
-9,157
-22% -$141K ﹤0.01% 1909
2023
Q4 		$670K Buy
41,527
+1,117
+3% +$14.2K ﹤0.01% 1824
2023
Q3 		$514K Sell
40,410
-1,717
-4% -$23.7K ﹤0.01% 1870
2023
Q2 		$589K Buy
42,127
+8,079
+24% +$116K ﹤0.01% 1867
2023
Q1 		$526K Buy
34,048
+11,123
+49% +$186K ﹤0.01% 1891
2022
Q4 		$376K Buy
22,925
+42
+0.2% +$683 ﹤0.01% 2038
2022
Q3 		$423K Buy
22,883
+10,004
+78% +$157K ﹤0.01% 1969
2022
Q2 		$169K Buy
+12,879
New +$142K ﹤0.01% 2194

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mirae Asset Global Investments's DCPH Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 32,370 shares — an estimated $492K sold.

Mirae Asset Global Investments first reported a position in DCPH in Q2 2022 and held it in 8 quarters. The position peaked at $670K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 32,370 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $492K.
  • Mirae Asset Global Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $670K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.